Search

Susanna Moore

Examiner (ID: 4754)

Most Active Art Unit
1624
Art Unit(s)
1624
Total Applications
1838
Issued Applications
1086
Pending Applications
196
Abandoned Applications
608

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11038799 [patent_doc_number] => 20160235754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/140874 [patent_app_country] => US [patent_app_date] => 2016-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61766 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15140874 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/140874
HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS Apr 27, 2016 Abandoned
Array ( [id] => 11400341 [patent_doc_number] => 20170020879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-26 [patent_title] => 'PYRAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/139361 [patent_app_country] => US [patent_app_date] => 2016-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22293 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15139361 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/139361
Pyrazolopyridyl compounds as aldosterone synthase inhibitors Apr 26, 2016 Issued
Array ( [id] => 11113527 [patent_doc_number] => 20160310497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/135121 [patent_app_country] => US [patent_app_date] => 2016-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 80936 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15135121 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/135121
Purine derivatives useful as HSP90 inhibitors Apr 20, 2016 Issued
Array ( [id] => 11032911 [patent_doc_number] => 20160229868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 15/099815 [patent_app_country] => US [patent_app_date] => 2016-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 38626 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15099815 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/099815
NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY Apr 14, 2016 Abandoned
Array ( [id] => 12603108 [patent_doc_number] => 20180092866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => SUBSTITUTED N-([1,1'-BIPHENYL]-3-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE ANALOGS AS INHIBITORS FOR BETA-CATENIN/B-CELL LYMPHOMA 9 INTERACTIONS [patent_app_type] => utility [patent_app_number] => 15/566568 [patent_app_country] => US [patent_app_date] => 2016-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65036 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 441 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566568 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/566568
SUBSTITUTED N-([1,1'-BIPHENYL]-3-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE ANALOGS AS INHIBITORS FOR BETA-CATENIN/B-CELL LYMPHOMA 9 INTERACTIONS Apr 13, 2016 Abandoned
Array ( [id] => 11090628 [patent_doc_number] => 20160287596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'Benzoxazole Kinase Inhibitors and Methods of Use' [patent_app_type] => utility [patent_app_number] => 15/092833 [patent_app_country] => US [patent_app_date] => 2016-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 139279 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092833 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/092833
Benzoxazole Kinase Inhibitors and Methods of Use Apr 6, 2016 Abandoned
Array ( [id] => 12239852 [patent_doc_number] => 20180072715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/563680 [patent_app_country] => US [patent_app_date] => 2016-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40023 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563680 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/563680
Imidazolonylquinolines and the use thereof as ATM kinase inhibitors Mar 30, 2016 Issued
Array ( [id] => 10997393 [patent_doc_number] => 20160194338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'SUBSTITUTED TETRAHYDROCARBAZOLE AND CARBAZOLES CARBOXAMIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 15/067915 [patent_app_country] => US [patent_app_date] => 2016-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 70283 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15067915 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/067915
SUBSTITUTED TETRAHYDROCARBAZOLE AND CARBAZOLES CARBOXAMIDE COMPOUNDS Mar 10, 2016 Abandoned
Array ( [id] => 12184011 [patent_doc_number] => 20180042948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-15 [patent_title] => 'BORON-DIPYRRIN COMPLEX AND MEDICAMENT CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/555721 [patent_app_country] => US [patent_app_date] => 2016-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11441 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555721 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/555721
Boron-dipyrrin complex and medicament containing the same Mar 3, 2016 Issued
Array ( [id] => 10988856 [patent_doc_number] => 20160185800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 15/059962 [patent_app_country] => US [patent_app_date] => 2016-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 70150 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15059962 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/059962
Certain chemical entities, compositions and methods Mar 2, 2016 Issued
Array ( [id] => 11872424 [patent_doc_number] => 09744172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Pyrazolopyrimidine compounds for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 15/055756 [patent_app_country] => US [patent_app_date] => 2016-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35286 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15055756 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/055756
Pyrazolopyrimidine compounds for the treatment of cancer Feb 28, 2016 Issued
Array ( [id] => 12680665 [patent_doc_number] => 20180118721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => PYRIMIDINE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 15/550383 [patent_app_country] => US [patent_app_date] => 2016-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31877 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550383 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/550383
PYRIMIDINE DERIVATIVES Feb 11, 2016 Abandoned
Array ( [id] => 15355499 [patent_doc_number] => 10526350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-07 [patent_title] => Process for the preparation of baricitinib and an intermediate thereof [patent_app_type] => utility [patent_app_number] => 15/548116 [patent_app_country] => US [patent_app_date] => 2016-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1844 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548116 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/548116
Process for the preparation of baricitinib and an intermediate thereof Feb 1, 2016 Issued
Array ( [id] => 11038798 [patent_doc_number] => 20160235755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-18 [patent_title] => 'HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK' [patent_app_type] => utility [patent_app_number] => 15/010619 [patent_app_country] => US [patent_app_date] => 2016-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20824 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15010619 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/010619
Heterocyclic compounds for the inhibition of PASK Jan 28, 2016 Issued
Array ( [id] => 12118705 [patent_doc_number] => 20180002292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'PROCESS FOR THE PRODUCTION OF CONDENSED IMIDAZOLO DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 15/546707 [patent_app_country] => US [patent_app_date] => 2016-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7547 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15546707 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/546707
Process for the production of condensed imidazolo derivatives Jan 27, 2016 Issued
Array ( [id] => 13717135 [patent_doc_number] => 20170369522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-28 [patent_title] => 3.ALPHA.-ETHYNYL, 3.BETA.-HYDROXY-5.ALPHA.-PREGNAN-20-OXIME FOR USE IN THE TREATMENT OF CNS DISORDERS [patent_app_type] => utility [patent_app_number] => 15/542800 [patent_app_country] => US [patent_app_date] => 2016-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6823 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542800 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/542800
3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders Jan 10, 2016 Issued
Array ( [id] => 13702541 [patent_doc_number] => 20170362225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 15/541875 [patent_app_country] => US [patent_app_date] => 2016-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20687 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541875 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/541875
Bicyclic compounds, compositions and medicinal applications thereof Jan 7, 2016 Issued
Array ( [id] => 10997373 [patent_doc_number] => 20160194319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'PYRIDOPYRIMIDINE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTERASE 3 (PDE3) INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/988830 [patent_app_country] => US [patent_app_date] => 2016-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8250 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988830 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/988830
Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof Jan 5, 2016 Issued
Array ( [id] => 12979489 [patent_doc_number] => 20170342032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => CARBAMATE COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/541799 [patent_app_country] => US [patent_app_date] => 2016-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7870 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541799 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/541799
Carbamate compound and use thereof Jan 4, 2016 Issued
Array ( [id] => 14727915 [patent_doc_number] => 10383333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-20 [patent_title] => Carbamate compound and use thereof [patent_app_type] => utility [patent_app_number] => 15/541821 [patent_app_country] => US [patent_app_date] => 2016-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8748 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541821 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/541821
Carbamate compound and use thereof Jan 4, 2016 Issued
Menu